Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Since 2021, Korean researchers have been providing a simple software development framework to users with relatively limited ...

SEOCHO-GU, SEOUL, SOUTH KOREA, January 1, 2026 /EINPresswire.com/ — AJ2 (CEO Gil Soo Jung) announced that it will demonstrate its proprietary algorithm–hardware integrated iris recognition platform at ...

The numbers tell a striking story. Forty-three percent of companies now use AI for hiring—nearly double last year's 26%. Yet ...

The USSR and its Eastern European satellites failed to keep pace with the West in the third industrial revolution, hastening ...

Since 2021, Korean researchers have been providing a simple software development framework to users with relatively limited ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

The rise of the AI gig workforce has driven an important shift from commodity task execution to first-tier crowd contribution ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Today's AI agents are a primitive approximation of what agents are meant to be. True agentic AI requires serious advances in reinforcement learning and complex memory.

Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...

These stocks could soar in 2026 and have excellent long-term opportunities. Artificial intelligence (AI) has driven the ...